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Abstract
Background: Human papillomavirus (HPV) is the main causative agent of cervical cancer, particularly high risk strains such
us HPV-16, -18 and -31. The viral encoded E2 protein acts as a transcriptional modulator and exerts a key role in viral DNA
replication. Thus, E2 constitutes an attractive target for developing antiviral agents. E2 is a homodimeric protein that
interacts with the DNA target through an a-helix of each monomer. However, a peptide corresponding to the DNA
recognition helix of HPV-16 E2 binds DNA with lower affinity than its full-length DNA binding domain. Therefore, in an
attempt to promote the DNA binding of the isolated peptide, we have designed a conjugate compound of the E2 a-helix
peptide and a derivative of the antibiotic distamycin, which involves simultaneous minor- and major-groove interactions.
Methodology/Principal Findings: An E2 a-helix peptide-distamycin conjugate was designed and synthesized. It was
characterized by NMR and CD spectroscopy, and its DNA binding properties were investigated by CD, DNA melting and gel
shift experiments. The coupling of E2 peptide with distamycin does not affect its structural properties. The conjugate
improves significantly the affinity of the peptide for specific DNA. In addition, stoichiometric amounts of specific DNA
increase meaningfully the helical population of the peptide. The conjugate enhances the DNA binding constant 50-fold,
maintaining its specificity.
Conclusions/Significance: These results demonstrate that peptide-distamycin conjugates are a promising tool to obtain
compounds that bind the E2 target DNA-sequences with remarkable affinity and suggest that a bipartite major/minor
groove binding scaffold can be a useful approach for therapeutic treatment of HPV infection.
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Introduction
Cervical cancer is a major cause of cancer-related death in
women. Human papillomavirus (HPV) is the main causative agent
of cervical cancer, in particular high risk strains such us HPV-16
and -18 followed by HPV-31 and -45 [1]. Despite recent advances
in preventive HPV vaccine development, such strategies are
unlikely to reduce the prevalence of HPV infections within the
next few years, due to their high cost and limited availability in
developing countries. In addition, preventive HPV vaccines may
not be capable of treating established HPV infections and HPV-
associated lesions, which account for high morbidity and mortality
worldwide. Thus, it is crucial to develop therapeutic strategies for
controllingHPVinfectionandassociatedmalignancies[2].HPVE2
protein acts as a transcriptional modulator and participates in viral
DNA replication and episomal copy number maintenance of the
viral genome [3]. Furthermore, E2 represses the transcription of E6
and E7 oncoproteins, and this ability is lost upon viral DNA
integration into the host genome. This event often occurs with the
disruptionoftheE2 open reading frame,leadingto the deregulation
of the expression of E6 and E7, essential for the transformation
process [4]. Hence, E2 constitutes an ideal target for HPV therapy.
In particular, molecules capable of binding the HPV E2 DNA-
recognition sequences with high specificity and affinity may
interfere with one key event of the viral life cycle: the interaction
betweentheE2transcriptionfactoranditstargetDNAsequences.It
is expected that these molecules will act with similar efficiency on all
the high-risk strains, as all these viruses have in common highly
conserved E2 DNAbinding sequences[5].Furthermore, targetinga
conserved DNA sequence, instead of a potentially mutable protein,
can overcome the problem of resistant virus generation, a major
drawback associated with antiviral agents.
There is a great deal of interest in obtaining small synthetic
mimics of transcription factors capable of reproducing their DNA-
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22409binding properties but also presenting good bioavailability [6,7].
E2 consists of an N-terminal transactivation domain and a C-
terminal DNA binding and dimerization domains (E2C), separat-
ed by a nonconserved hinge domain [8]. E2C is a symmetric
dimer that interacts with the major groove of the target DNA
through two a-helices, one of each monomer [8,9,10]. A peptide
corresponding to the DNA recognition helix of HPV-16 E2
displays only residual structure and binds DNA with low affinity
[11,12]. Recently, it was demonstrated in various biological
systems that the appropriate tethering of a monomeric DNA-
binding helix to a distamycin (Dst)-like tripyrrole, which binds with
moderate affinity the minor groove adjacent to the helix target site,
provides for specific binding [13,14,15]. The natural cognate
DNAs of HPV-16 and -18 E2 present, in the region adjacent to the
DNA-sequence recognized by E2 (CGGT), the sequence AAAT,
which is one of the sequences with the highest binding affinities for
Dst [16]. Therefore, we decided to explore whether conjugation of
a peptide corresponding to the DNA-binding a-helix of the E2
protein from HPV-16 with a Dst derivative could improve the
affinity of the peptide for specific DNA. Here we report the design,
synthesis, characterization and DNA-binding properties of a
conjugate between a peptide corresponding to the a-helix of the
HPV-16 E2 protein and a Dst tripyrrole derivative carrying a
primary amino function in the tether between both moieties.
These results show the potential utility of this kind of hybrids as a
new class of molecules for the treatment of HPV infections and are
encouraging for the design of E2 conjugates with alternative
linkers that can bind DNA with higher specificity and affinity.
Materials and Methods
In this study we have worked with the following compounds:
aE2: peptide corresponding to the DNA-binding a-helix of the E2
protein from HPV-16; aE2-Ala: the aE2 peptide but with alanine
in positions 299, 302 and 306; aE2-conj: the aE2-Ala peptide Dst
conjugate (see Figure 1B below).
Computer modelling
The model for the simultaneous interaction of Dst and a peptide
corresponding to the DNA-binding a-helix of the E2 protein with
DNA was constructed using the program Insight II and was based
on the crystal structures of the complexes of E2C from HPV-18
(PDB 1F9F) [5] and Dst (PDB 1JTL) [17] with their cognates
DNAs. Both structures were superimposed by phosphate align-
ment to get an appropriate arrangement for connecting the two
moieties. The linker was designed by using the module Builder of
this program. We considered only one of the two possible binding
modes of Dst to DNA for designing the conjugate [17].
Synthesis of aE2-conj
Linear peptides were synthesized by an automated SPPS (ABI
433A Peptide Synthesizer) using Fmoc chemistry (coupling with
HBTU/HOBt/DIPEA in NMP). Purification of the crude
conjugate was performed by preparative RP-HPLC (Vydac C18
column). Purified products were further characterized by Kom-
pact Axima-CFR MALDI-TOF mass spectrometer (see Text S1).
DNA Synthesis
Single-stranded oligonucleotides were purchased, SDS-PAGE
purified, from Primm srl (Milano, Italy). Double-stranded
oligonucleotides were annealed by mixing equal amounts of each
strand in 10 mM Bis-Tris-HCl buffer, pH 7.0 and 50 mM NaCl,
incubating 5 minutes at 95uC, and slowly cooling to 25uC for
16 hours. Completeness of hybridization was checked by native
polyacrylamide gel electrophoresis.
NMR Spectrosocopy
The conjugate aE2-conj (3 mM) and the corresponding
isolated peptide, aE2-Ala (KGDANTAKCARYRAKKHA),
(7 mM) were dissolved in a 40% TFE-d3 - 60% 20 mM phosphate
buffer solution pH 6.5 containing 2 mM DTT and 0.01% NaN3.
The NMR experiments were performed at 25uC using a Bruker
Avance 700 and Avance 400 spectrometers equipped with triple
resonance probes incorporating self-shielded gradient coils. All the
heteronuclear correlation experiments were carried out at natural
abundance. Pulsed field gradients were appropriately employed to
achieve suppression of the solvent signal and spectral artefacts.
Quadrature detection in the indirectly detected dimensions was
obtained using the States-TPPI method [18] or the echo-antiecho
method, and the spectra were processed on Silicon Graphics
workstations by the NMRPipe software [19] and analyzed using
NMRView [20]. All proton, nitrogen and carbon resonances were
assigned using 2D spectra. TOCSY (mixing time 60 ms) was used
to identify the spin systems. Natural abundance [
1H-
13C] HMQC
optimized for observing aliphatic or aromatic regions and
[
1H-
13C] HMQC-TOCSY (with mixing times of 40, 60 and
80 ms) spectra were used to assist with cross-peaks assignment.
NOESY spectra (with mixing times of 0.150 s and 0.250 s) were
used for establishing the sequential assignment of the spin systems.
15N chemical shifts were measured from a natural abundance
[
15N-
1H] HSQC experiment.
CD Spectroscopy
CD measurements were carried out on a Jasco J-810
spectropolarimeter using a Peltier temperature-controlled sample
holder and a 0.1 cm path length cell. Near UV experiments were
performed with 2 mM hemisite E2-Dst site alone and mixtures
containing 10 mM aE2-conj or Dst at 25uC. Far UV spectra and
KD determination experiments were performed at 5uC in solutions
containing 5 mM peptide after incubating 20 minutes at room
temperature with a stoichiometric amount of the corresponding
hemisite.
CD titration experiments were done with 5 mM aE2-conj and
increasing concentrations of hemisite E2-Dst. The change in
helical population was detected following the ellipticity change at
222 nm and fitted to a 1:1 binding model using the following
equation:
DI~
0:5DIt
peptide ½ 
:f peptide ½  z DNA ½  zKD ðÞ {
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
peptide ½  z DNA ½  zKD ðÞ
2{4 pepetide ½  DNA ½ 
q  
where DI is the signal change at each DNA concentration, DIt is
the signal difference between the free peptide and the complex, KD
is the equilibrium dissociation constant and [peptide] and [DNA]
are the respective total concentrations.
All CD experiments were done in 10 mM phosphate pH 7.0,
1 mM DTT, 100 mM NaCl buffer.
DNA melting experiments
UV DNA melting experiments were conduced with the
oligonucleotide (2 mM) in the absence and in the presence of an
excess of peptide (10 mM) in the same buffer conditions used in
CD experiments. Absorbance at 260 nm was measured as a
function of temperature using the absorbance mode of the Jasco
HPV E2 Mimics: A Distamycin-Peptide Conjugate
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holder. The melting temperature (Tm) was determined as the
midpoint of the curve. Each Tm is the mean value obtained from
three independent measurements.
Electrophoretic Mobility Shift Assay (EMSA)
Reaction mixtures contained 2 mM fluorescein-labelled oligo-
nucleotides and increasing amounts of the studied peptides.
Mixtures were incubated 60 min at room temperature in a final
volume of 10 mL in 25 mM phosphate pH 7.0, 1 mM DTT.
Mixtures were loaded continuously into running non-denaturing
10% polyacrylamide gels containing TBE 0.56(0.1 M Tris-HCl
pH 8.0, 0.15 M sodium borate, 4 mM EDTA). The gels were
resolved at 4 V/cm, 10uC for 2 h. Fluorescein bands correspond-
ing to the free oligonucleotide were detected by UV and fitted to a
1:1 binding model (the same equation than in the CD titration but
with a fixed concentration of peptide and increasing concentra-
tions of DNA). Because of the peptide’s high isoelectric point
Figure 1. Design of aE2-conj. A. Hypothetic model for the simultaneous binding of the aE2 peptide and Dst to DNA. DNA is depicted in
cyan and Dst in magenta. The peptide positions involved in backbone DNA recognition are displayed in blue; in red are shown residues involved in
specific DNA bases interactions; while in yellow are the hydrophobic residues mutated to alanine to minimize hydrophobic interactions. The distance
between the N2 of Dst and the N-atoms of the guanidinium group of R296 is indicated. The lower panel shows the alignment of the DNA binding
helices of E2 proteins from HPV-16 and -18 strains, and the sequence of the peptide used for synthesizing aE2-conj. The colour coding is the same
used in the model. Position 296 chosen to attach the Dst moiety is boxed. B. Chemical structure of aE2-conj. C. Qualitative model of aE2-conj
bound to DNA.
doi:10.1371/journal.pone.0022409.g001
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directions [11], so the complex band was not observed in the gels
and only free DNA was quantified in the experiments.
Results and Discussion
Design of the conjugate aE2-conj
In order to design our conjugate, we constructed a model for the
simultaneous interaction of Dst and the E2 helix peptide with
adjacent DNA sites based on the structures of the complexes of the
HPV-18 E2C domain [5] and Dst [17] with their cognates DNAs
(Figure 1A). First, we changed hydrophobic residues in the
peptide, which are not involved in DNA recognition, into alanines
to reduce unfavourable hydrophobic interactions, to augment the
water solubility, and possibly to increase the helix tendency of the
peptide [21]. Second, side chain of R296 is very close to the N2 of
Dst (,8A ˚ between N2 of Dst and the N-atoms of the guanidinium
group of R296). Therefore, these positions were chosen for
tethering the peptide and the tripyrrole derivative. As R296 is not
involved in the interaction with DNA bases [10,22] and, since
lysine was successfully used to attach linkers between peptides and
tripyrrole units [14,23,24], we introduced in position 296 a lysine.
Finally, the selection of the linker is crucial to have high affinities
hybrids [14,15]. We designed a Dst-peptide conjugate, named
aE2-conj (Figure 1B). In this compound, the Dst bound to a
pentylamine is connected to the nitrogen-f of the side chain of the
K296 by a urea functionality [14]. According to our model, this
linker length with a pentylene between the urea and the pyrrolic
nitrogens should be adequate to allow the simultaneous binding of
both moieties to DNA, the Dst in the minor groove and the peptide
in the major groove (Figure 1C). The additional primary
propylamine, which is protonated at the working pH, may also
favour the affinity towards the negatively charged nucleic acid
[15].
Synthesis and NMR characterization of aE2-conj
The tripyrrole unit was prepared following reported procedures
[13]. Selective functionalization at K296, required to attach the
minor groove binding moiety, was performed through the
introduction of an Alloc-protected side chain lysine residue [23].
Removal of the Alloc-protecting group and attachment of the
tripyrrole unit was performed with the protected peptide still
bound to the resin. Coupling reaction was carried out by
sequential addition of the bifunctional conjugating agent dis-
uccinimidyl carbonate and the amino pyrrole. After standard
cleavage-deprotection and purification steps, we obtained the
desired conjugated aE2-conj in approximately 20% yield
considering peptide synthesis (see Text S1).
aE2-conj was characterized by NMR spectroscopy (see Text
S2, Figure S1 and Tables S1 and S2). The coupling with the Dst
Figure 2. Spectroscopic interaction evidence of aE2-conj and
DNA. A. Near-UV CD spectrum at 25uC of the oligonucleotide hemisite
E2-Dst (2 mM) alone, after the addition of 10 mM Dst or aE2-conj. B. Far-
UV CD spectrum of aE2-conj alone, in the presence of hemisite E2-Dst,
hemisite E2-non Dst, hemisite non E2-Dst or hemisite non E2-non Dst. C.
Far-UV CD spectrum of aE2-conj alone and in the presence of hemisite
E2-Dst (upper panel), and of aE2-Ala alone and in the presence of
hemisite E2-Dst (lower panel). CD measurements in B and C were
performed at 5uC in solutions containing 10 mM phosphate buffer
pH 7.0, 100 mM NaCl, and 5 mM peptide after incubating 20 minutes at
room temperature with 5 mM ds-oligonucleotide, when present. B and
C show the spectrum of the mixture (peptide and DNA) minus the
spectra of the corresponding DNA alone.
doi:10.1371/journal.pone.0022409.g002
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of the peptide moiety respect to the isolated peptide (Figure S1C).
Analysis of the secondary chemical shifts in the aE2-conj peptide
indicates that in a 4:6 TFE-water solution it adopts an a-helical
conformation from K296 to H309 (Figure S2). In contrast, in
aqueos solution the peptide moiety is mainly unstructured as
shown by CD spectroscopy (Figure 2B). Additionally, the
secondary chemical shift analysis shows that the a-helix population
is mainly the same as that found for the isolated HPV-16 E2 helix
peptide, aE2 (Figure S2). This result points out that the
substitution of three hydrophobic residues for alanines was not
sufficient for augmenting the helix propensity of the peptide, at
least in the TFE: water mixture. Similar helical propensity of aE2,
aE2-conj and aE2-Ala was confirmed by CD spectroscopy in
TFE titration experiments following molar ellipticty at 222 nm
(Text S3, Figure S3).
DNA binding properties of aE2-conj
A first evidence of the interaction of aE2-conj with DNA was
obtained from CD spectroscopy (Figure 2, and see Table 1 for
sequences of oligonucleotides used in this work). The appearance
of an intense positive band around ,330 nm is observed in the
spectrum of the oligonucleotide hemisite E2-Dst upon addition of
an excess of aE2-conj (Figure 2A). This is an indication of the
tripyrrole moiety of aE2-conj inserting into the DNA minor
groove. The fact that only a slight increase in the ellipticity at
330 nm is induced in the spectrum of hemisite E2-Dst after adding
Dst shows that both moieties of aE2-conj must be present for a
tight binding to DNA. On the other hand, the far-UV CD
spectrum of aE2-conj in aqueous solution corresponds to that of a
mostly unfolded peptide (Figure 2B). However, a significant
increase in the negative CD signal at 222 nm in the spectrum of
aE2-conj was induced when added hemisite E2-Dst, indicating
the folding in a-helix of the peptide moiety upon DNA binding.
Control oligonucleotides, lacking the E2 or the Dst recognition
sequences, or both, produced a minor increase of the 222 nm
band, suggesting some nonspecific but weaker binding. Addition-
ally, the CD signal at 222 nm is not significantly augmented in the
spectrum of the isolated peptide aE2-Ala when incubated with
hemisite E2-Dst oligonucleotide (Figure C, lower panel). These
results demonstrate that interaction of both peptide and Dst are
necessary in aE2-conj for a tight binding.
Supplementary evidence of specific binding of aE2-conj to
DNA was obtained by ds-DNA melting temperature (Tm)
measurements (Figure 3 and Table 2). When some compound
binds ds-DNA, the duplex is stabilized by the interaction and the
Tm of the nucleic acid is increased. Tighter the binging is, higher
the melting temperature. The oligonucleotide hemisite E2-Dst
melts at 58.5uC( Figure 3A). In the presence aE2 or aE2-Ala the
melting is slightly augmented, due to the weak interaction of the
isolated peptides with specific DNA [11]. In contrast, in the
presence of Dst the increase in the melting temperature of hemisite
E2-Dst is higher (7.0uCv s,2uC). This augment reflects the
Figure 3. DNA melting curves. A. Melting curves of the
oligonucleotide hemisite E2- Dst alone, in the presence of aE2, aE2-
Ala, Dst plus aE2-Ala, Dst and aE2-conj. B. Melting curves of the
oligonucleotide Iset non E2-non Dst alone and in the presence of aE2-
conj. Table 2 summarizes these results.
doi:10.1371/journal.pone.0022409.g003
Table 1. Sequences of duplex oligonucleotides used in this
study.
Oligonucleotides
a Sequence
a
hemisite E2-Dst
b GTA GCA Caa atC GGT TGA
TCA ACC Gat ttG TGC TAC
hemisite E2-non Dst GTA GCA CAG CTC GGT TGA
TCA ACC GAG CTG TGC TAC
hemisite non E2-Dst GTA GCA Caa atT GCG TGA
TCA CGC Aat ttG TGC TAC
hemisite non E2-non Dst GTA GCA CAG CTT GCG TGA
TCA CGC AAG CTG TGC TAC
Iset non E2-non Dst ACA TGG ACC TGT CAA GTA
TAC TTG ACA GGT CCA TGT
aThe E2 hemisite is underlined and the Dst binding site is indicated in italics and
in lower-case letters.
bThe hemisite E2-Dst corresponds to half E2 target site 35.
doi:10.1371/journal.pone.0022409.t001
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the CD measurements. Finally, when aE2-conj is added the Tm
is the highest measured (70.0uC), showing that a tight binding is
obtained only when both moieties of aE2-conj are present.
Interestingly, the Tm in the simultaneous presence of aE2-Ala
and Dst was even lower than in the presence of only Dst, indicating
that the effect is not additive. On the other hand, aE2-conj
produces a higher increase in the Tm of the hemisite E2-Dst than
in the Tm of two ds-oligonucleotides not containing the E2 nor the
Dst binding sites: hemisite non E2-non Dst and Iset non E2-non
Dst (DTm of 6.0uC for both control oligonucleotides vs. 11.5uC for
hemisite E2-Dst, Figure 3B and Table 2), suggesting that the
binding of aE2-conj is specific.
The full E2C domain in solution binds DNA with high affinity
(KD in the low nanomolar range when determined in solution) and
specificity (,1000 fold) [9,25]. However, when the affinity was
measured by gel shift experiments, the KD for a complex between
E2C and a specific ds-oligonucleotide was in the mM order [9].
Dissociation constants of aE2-conj and aE2 to specific and
unspecific oligonucleotides at 25uC were determined by gel shift
experiments (Table 3 and Figure 4A). The complex between the
aE2 peptide and hemisite E2-Dst gave a KD of ,6 mM, in
agreement with previous measurements [11,12]. The KD for a
complex between aE2 and the randomnized oligonucleotide Iset
non E2-non Dst was of ,50 mM, also in perfect agreement with
previous measurements. On the contrary, the complex between
the conjugate aE2-conj and hemisite E2-Dst presented a KD of
,0.13 mM. Thus aE2-conj displays an increment of affinity for
the target DNA of one order and a half (KD (aE2)/KD (aE2-
Table 3. Dissociation constants.
Complex KD (mM)
gel shift
experiments CD titration
aE2/hemisite E2-Dst 6.362.6 n.d.
a
aE2/Iset non E2-non Dst ,50 n.d.
aE2-conj/hemisite E2-Dst 0.1360.09 0.1060.15
aE2-conj/Iset non E2-non Dst 1.2260.75 n.d.
E2C/hemisite E2-Dst ,1
b n.d.
an.d.: not determined.
bRef. 9.
doi:10.1371/journal.pone.0022409.t003
Table 2. DNA melting temperatures.
hemisite E2-Dst
Tm (6C)
a DTm (6C)
alone 58.560.3 –
+Dst 65.560.4 7.060.7
+aE2-Ala 61.060.3 2.560.6
+aE2 60.560.5 2.060.8
+aE2-conj 70.060.3 11.560.6
+aE2-Ala +Dst 64.560.4 6.060.7
hemisite non E2-non Dst
alone 64.460.4 –
+aE2-conj 70.060.4 6.060.8
Iset non E2-non Dst
alone 60.260.2
+aE2-conj 66.260.3 6.060.5
amean values 6 standard deviation between three independent
measurements.
doi:10.1371/journal.pone.0022409.t002
Figure 4. Equilibrium dissociation constant determination. A.
Electrophoretic mobility shift assay at room temperature, complex
fraction as a function of peptide/DNA ratio: aE2-conj/hemisite E2-Dst,
aE2/hemisite E2-Dst, aE2-conj/Iset non E2-non Dst. The inset shows a
picture of the corresponding gel assays. B. Molar ellipticity change at
222 nm as a function of hemisite E2-Dst/aE2-conj ratio, experiment
performed at 5uC. Both titration experiments were carried out in 10 mM
phosphate pH 7.0, 100 mM NaCl, 1 mM DTT buffer. Lines are fits to a
quadratic equation corresponding to 1:1 binding model. Dash lines in
figure B are added to show 1:1 stoichiometry.
doi:10.1371/journal.pone.0022409.g004
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affinity for specific DNA of one order of magnitude, when
measured in the same conditions [9]. The specificities of aE2 and
aE2-conj are similar (KD (Iset non E2-non Dst)/KD (Iset non E2-
non Dst) is 8 and 9 for aE2 and aE2-conj, respectively).
The KD of aE2-conj hemisite E2-Dst complex was also
determined by CD titration at 222 nm at 5uC (0.1060.15 mM,
Table 2 and Figure 4B). As expected, the value thus obtained is
slightly lower than the value obtained by gel shift at 25uC. The
observed differences are not related with the incubation buffer
conditions but with dissociating conditions of the EMSA assay
[26]. Moreover, the value might be overestimated because this
measurement was performed at high concentrations to stress the
helical signal in the CD spectrum. The CD experiment
additionally shows that the stoichiometry of the complex is 1:1.
Conclusions
In this study we have demonstrated that it is possible, by
properly conjugating the peptide to a Dst-like tripyrrole unit, to
increase the affinity of the monomeric aE2 peptide for specific
binding to its cognate DNA. We have designed a conjugate
carrying a primary amino function in the tether linking the peptide
and the Dst moieties to facilitate interaction with the phosphate
DNA-backbone. Our conjugate displays a ,50-fold increase of the
affinity for specific DNA respect to the peptide alone and a ,10-
fold increase when compared with the full-length domain, also
measured by gel shift experiments [9]. These results are
encouraging for the design of new E2 conjugates with alternative
linkers with higher specificities and better affinities capable of
acting as antiviral agents in HPV infections.
Work to design new more potent conjugates and to structurally
characterize them is currently in progress, in order to possibly
further understand the factors that govern sequence-specific
protein-DNA interactions.
Supporting Information
Figure S1 NMR chemical shift assignments of aE2-conj.
A. Chemical structure and numbering of aE2-conj. Inset:
An alternative chemical connection between the peptide and the
Dst derivative moieties. B.
1H-monodimensional spectrum
of aE2-conj.C .[
13C,
1H]-HMQC spectra of aE2-Ala and
aE2-conj (right and left panels, respectively). The spectra were
recorded in a 700 MHz spectrometer at 25uC in 4:6 TFE:aqueous
solution. Residue chemical shift assignment of the peptide moiety
is indicated in black and signals corresponding to the linker and
Dst portions of the conjugate are indicated in red. In bold letters
are shown the crosspeaks corresponding to residue in position 296
in both compounds, for the isolated peptide 296 is an alanine while
is a lysine in the conjugate. (Imp: Impurity).
(TIF)
Figure S2 Secondary chemical shifts for aE2-conj and
aE2. Plot of the chemical shift differences between the observed
resonances and values found in a random coil conformation,
Dd=d(obsd) - d(random coil), vs. the position along the peptidic
sequence for
13Ca,
13Cb and
1Ha on the top, medium, and lower
panel, respectively, for aE2-conj (N) and aE2 (#). Positive
deviations of the shifts of Ca and negative of Cb and Ha are
indicative of a-helical conformation.
(TIF)
Figure S3 TFE titration for aE2-Ala, aE2 and aE2-conj.
Molar ellipticity at 222 nm for aE2-Ala, aE2, aE2-conj as a
function of TFE concentration. Line corresponds to the fit to a
two-state coil-helix equilibrium proposed.
(TIF)
Table S1
1H,
13C and
15N Chemical shifts assignments
of the peptide moiety of aE2-conj.
(DOCX)
Table S2
1H,
13C, and
15N chemical shifts assignments
of the Dst moiety of aE2-conj.
(DOCX)
Text S1 aE2-conj purification.
(DOC)
Text S2 NMR chemical shit assignments of aE2-conj.
(DOC)
Text S3 TFE titrations.
(DOC)
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